Cargando…
Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292513/ http://dx.doi.org/10.1186/2051-1426-2-S3-P234 |
_version_ | 1782352491836342272 |
---|---|
author | Johnson, Christopher B Riesenberg, Brian Neitzke, Dan Jeng, Emily K Marcus, Warren D Cole, David Wong, Hing C Rubinstein, Mark P |
author_facet | Johnson, Christopher B Riesenberg, Brian Neitzke, Dan Jeng, Emily K Marcus, Warren D Cole, David Wong, Hing C Rubinstein, Mark P |
author_sort | Johnson, Christopher B |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4292513 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42925132015-01-15 Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice Johnson, Christopher B Riesenberg, Brian Neitzke, Dan Jeng, Emily K Marcus, Warren D Cole, David Wong, Hing C Rubinstein, Mark P J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4292513/ http://dx.doi.org/10.1186/2051-1426-2-S3-P234 Text en Copyright © 2014 Johnson et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Johnson, Christopher B Riesenberg, Brian Neitzke, Dan Jeng, Emily K Marcus, Warren D Cole, David Wong, Hing C Rubinstein, Mark P Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice |
title | Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice |
title_full | Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice |
title_fullStr | Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice |
title_full_unstemmed | Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice |
title_short | Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice |
title_sort | combinatorial therapy with an il-15 superagonist (alt-803) and anti-pd-l1 mab augment t cell mediated anti-tumor immunity in mice |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292513/ http://dx.doi.org/10.1186/2051-1426-2-S3-P234 |
work_keys_str_mv | AT johnsonchristopherb combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice AT riesenbergbrian combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice AT neitzkedan combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice AT jengemilyk combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice AT marcuswarrend combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice AT coledavid combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice AT wonghingc combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice AT rubinsteinmarkp combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice |